Pricing Log in Create free account

Abivax SA Sponsored ADR (ABVX) vs Kymera Therapeutics, Inc. (KYMR)

Abivax SA Sponsored ADR and Kymera Therapeutics, Inc. are both Biotechnology companies. Kymera Therapeutics, Inc. is the larger, with a market value of $9.0B against $8.1B — 1.1× the size. Abivax SA Sponsored ADR has the higher net margin (0.00% vs −285.3%) and the higher return on invested capital (0.00% vs −26.7%). Across the 14 metrics below, Kymera Therapeutics, Inc. leads on 9 and Abivax SA Sponsored ADR on 5.

Valuation

Metric ABVX KYMR Biotechnology median
P/E n/m n/m 8.50
P/S n/m 97.97 9.71
P/B 16.42 6.82 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 91.40 9.21
Earnings yield (6.90%) (3.09%) (33.15%)
Free cash flow yield (3.23%) (2.31%) (25.50%)

Profitability

Metric ABVX KYMR Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (333.50%) 0.00%
Net margin 0.00% (285.33%) 0.00%
Free cash flow margin 0.00% (226.62%) 0.00%
Return on equity (249.78%) (24.15%) (56.36%)
Return on assets (137.67%) (21.58%) (48.04%)
Return on invested capital 0.00% (26.72%) 0.00%

Growth

Metric ABVX KYMR Biotechnology median
Revenue growth (TTM) — 134.84% 6.02%
EPS growth (last fiscal year) (80.20%) (23.83%) 30.26%
Revenue growth, 5-year CAGR — 2.87% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVX KYMR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.97 10.34 4.72
Net debt to EBITDA 2.19 2.42 0.96

Dividend

Metric ABVX KYMR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABVX KYMR Biotechnology median
Market cap 8.09b 8.99b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack